Home / Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial unknow ★ 5.0 · 41 reads Sign in to save this Request CodeZLIB.IO18490945 Published2022 Pages1 LanguageUnknown